MILLENNIUM MANAGEMENT LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-16 4:12 pm Sale |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
MILLENNIUM MANAGEMENT LLC | 911,465 1.500% |
-1,381,362 (-60.25%) |
Filing |
| 2023-05-31 4:17 pm Purchase |
2023-05-22 | 13G | Inozyme Pharma, Inc. INZY |
MILLENNIUM MANAGEMENT LLC | 2,292,827 5.200% |
2,292,827 (New Position) |
Filing |